Abstract:
Acute respiratory diseases are the most common among
all diseases. Given the variety of symptoms of acute
respiratory viral infections, various groups of drugs are
used to treat them, however, combined drugs are popular
among the population and clinic doctors. This is
"Grippomix" - a combined drug containing paracytamol,
rimantadine, cetirizine, ascarbic acid, the effectiveness
and safety of which was studied in this study. The
presence of almost all the necessary active ingredients in
a single form used for the complex treatment of acute
respiratory viral infections contributed to an increase in
patients' compliance with treatment, facilitating the
clinical course of the disease, reducing the risk of
complications. This helps to reduce the need for
antibiotic therapy
